Feed FTRE
FT

Fortrea Holdings Inc. FTRE NASDAQ · Healthcare · United States

$19.79 -2.03% -$0.41

Summary

29 / 100 · Bulios Score

What speaks for it

None of the indicators we track stands out on the positive side.

What to watch

  • The company made a loss over the last 12 months.
  • Operating profit does not even cover the interest on its debt.
  • The share price is above the Bulios Fair Price.
  • Revenue fell by 1.4% a year over the last 3 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Overvalued Price today $19.79

By our assumptions the business is worth less than its shares cost today.

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Slowly

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue fell by 1.4% a year over the last 3 years. For the next fiscal year analysts expect revenue to fall by 1.7%.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $68.7M.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 9.0 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $23.44 is 18% above today's price. 54% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Clinical Services Segment brings in 100% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy